EverImmune Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

EverImmune General Information

Description

Developer of live biotherapeutic products designed to improve the efficacy of immunotherapy in cancer patients. The company specializes in developing technology that utilizes gut microbiota to restore responsiveness to immune checkpoint inhibitors, employing theragnostic approaches that combine diagnostic and therapeutic technologies, enabling cancer patients to potentially improve treatment outcomes and address primary resistance issues.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 39 Rue Camille Desmoulins
  • 94800 Villejuif
  • France
+33 0
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 39 Rue Camille Desmoulins
  • 94800 Villejuif
  • France
+33 0

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EverImmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Debt - General 19-Sep-2023 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2022 Completed Startup
2. Early Stage VC (Series A) 30-Nov-2021 $5.71M $5.71M Completed Pre-Clinical Trials
1. Spin-Off 26-May-2016 Completed Pre-Clinical Trials
To view EverImmune’s complete valuation and funding history, request access »

EverImmune Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of live biotherapeutic products designed to improve the efficacy of immunotherapy in cancer patients. The comp
Drug Discovery
Villejuif, France
4 As of 2025

San Diego, CA
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EverImmune Competitors (8)

One of EverImmune’s 8 competitors is Bloom Science, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bloom Science Venture Capital-Backed San Diego, CA
GlycosBio Venture Capital-Backed Houston, TX
AbCellera Biologics Formerly VC-backed Vancouver, Canada
Alveolus Bio Venture Capital-Backed Birmingham, AL
LifeMine Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 8 competitors. Get the full list »

EverImmune Patents

EverImmune Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4794707-A1 Bacterial composition comprising akkermansia species, for improving the response to car t-cell therapy Pending 19-Oct-2023
AU-2022297690-A1 Methods for diagnosing a cancer- or antibiotics-induced dysbiosis and their use for improving cancer treatment by immunotherapy Pending 21-Jun-2021
CA-3223488-A1 Methods for diagnosing a cancer- or antibiotics-induced dysbiosis and their use for improving cancer treatment by immunotherapy Pending 21-Jun-2021
EP-4359795-A1 Methods for diagnosing a cancer- or antibiotics-induced dysbiosis and their use for improving cancer treatment by immunotherapy Active 21-Jun-2021
EP-4359795-B1 Methods for diagnosing a cancer- or antibiotics-induced dysbiosis and their use for improving cancer treatment by immunotherapy Active 21-Jun-2021 G01N33/575
To view EverImmune’s complete patent history, request access »

EverImmune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EverImmune Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Matwin Accelerator/Incubator
Gustave Roussy Corporation
To view EverImmune’s complete investors history, request access »

EverImmune FAQs

  • When was EverImmune founded?

    EverImmune was founded in 2016.

  • Where is EverImmune headquartered?

    EverImmune is headquartered in Villejuif, France.

  • What is the size of EverImmune?

    EverImmune has 4 total employees.

  • What industry is EverImmune in?

    EverImmune’s primary industry is Drug Discovery.

  • Is EverImmune a private or public company?

    EverImmune is a Private company.

  • What is EverImmune’s current revenue?

    The current revenue for EverImmune is .

  • How much funding has EverImmune raised over time?

    EverImmune has raised $9.5M.

  • Who are EverImmune’s investors?

    Matwin and Gustave Roussy have invested in EverImmune.

  • Who are EverImmune’s competitors?

    Bloom Science, GlycosBio, AbCellera Biologics, Alveolus Bio, and LifeMine are some of the 8 competitors of EverImmune.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process